AXL activation promotes adaptive resistance to KRAS-G12C inhibitors in KRASG12C-mutated non-small cell lung cancer

被引：0
|
作者：
Morimoto, Kenji
Yamada, Tadaaki
Hirai, Soichi
Katayama, Yuki
Kunimasa, Kei
Sasaki, Takaaki
Nishida, Makoto
Watanabe, Satoshi
Shiotsu, Shinsuke
Uehara, Hisanori
Takayama, Koichi
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-1941
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1941
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Role of AXL activation on adaptive resistance to KRAS-G12C inhibitors in KRAS-G12C-mutated non-small cell lung cancer
    Yamada, T.
    Morimoto, K.
    Hirai, S.
    Katayama, Y.
    Kunimasa, K.
    Sasaki, T.
    Nishida, M.
    Watanabe, S.
    Shiotsu, S.
    Uehara, H.
    Takayama, K.
    ANNALS OF ONCOLOGY, 2023, 34 : S194 - S194
  • [2] Mechanisms of resistance to KRASG12C inhibitors in KRASG12C-mutated non-small cell lung cancer
    Chour, Ali
    Toffart, Anne-Claire
    Berton, Elodie
    Duruisseaux, Michael
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [3] Adaptive resistance to KRAS-G12C inhibitors through AXL activation in KRAS-G12C mutant tumor cells
    Morimoto, Kenji
    Yamada, Tadaaki
    Hirai, Soichi
    Katayama, Yuki
    Yano, Seiji
    Horinaka, Mano
    Sakai, Toshiyuki
    Tokuda, Shinsaku
    Takayama, Koichi
    CANCER SCIENCE, 2024, 115 : 111 - 111
  • [4] Tissue factor overexpression promotes resistance to KRAS-G12C inhibition in non-small cell lung cancer
    Zhang, Yu
    Liu, Liang
    Pei, Jinpeng
    Ren, Zhiqiang
    Deng, Yan
    Yu, Ker
    ONCOGENE, 2024, 43 (09) : 668 - 681
  • [5] Intracranial responses with selective KRAS-G12C inhibitors in non-small cell lung cancer
    Lu, Kevin
    Husain, Hatim
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (06) : 1335 - 1337
  • [6] Tissue factor overexpression promotes resistance to KRAS-G12C inhibition in non-small cell lung cancer
    Yu Zhang
    Liang Liu
    Jinpeng Pei
    Zhiqiang Ren
    Yan Deng
    Ker Yu
    Oncogene, 2024, 43 : 668 - 681
  • [7] Coexisting Genomic Alterations in Risk Stratification of KRASG12C-Mutated Non-Small Cell Lung Cancer
    Heng, Sarina Z. W.
    Hoo, Regina
    Tan, Daniel S. W.
    CANCER DISCOVERY, 2023, 13 (07) : 1513 - 1515
  • [8] Resistance to KRASG12C Inhibitors in Non-Small Cell Lung Cancer
    Blaquier, Juan Bautista
    Cardona, Andres Felipe
    Recondo, Gonzalo
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [9] Activity and resistance to KRASG12C G12C inhibitors in non-small cell lung cancer and colorectal cancer
    Ye, Wei
    Lu, Xin
    Qiao, Yue
    Ou, Wen-Bin
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2024, 1879 (03):
  • [10] Tackling KRASG12C-mutated non-small-cell lung cancer: iteration and exploration
    Luo, Jia
    Villaruz, Liza C.
    LANCET RESPIRATORY MEDICINE, 2024, 12 (08): : 576 - 577
12345